KAMADA LTD (KMDA) Stock Fundamental Analysis
NASDAQ:KMDA - Nasdaq - IL0010941198 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 562 industry peers in the Biotechnology industry. KMDA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. KMDA is not valued too expensively and it also shows a decent growth rate. These ratings could make KMDA a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
KMDA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
KMDA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of KMDA (3.88%) is better than 92.88% of its industry peers.
KMDA's Return On Equity of 5.57% is amongst the best of the industry. KMDA outperforms 93.42% of its industry peers.
KMDA has a Return On Invested Capital of 4.91%. This is amongst the best in the industry. KMDA outperforms 93.59% of its industry peers.
KMDA had an Average Return On Invested Capital over the past 3 years of 2.98%. This is significantly below the industry average of 14.31%.
The 3 year average ROIC (2.98%) for KMDA is below the current ROIC(4.91%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.88% | ||
| ROE | 5.57% | ||
| ROIC | 4.91% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 8.99%, KMDA belongs to the best of the industry, outperforming 93.24% of the companies in the same industry.
In the last couple of years the Profit Margin of KMDA has declined.
Looking at the Operating Margin, with a value of 12.46%, KMDA belongs to the top of the industry, outperforming 94.48% of the companies in the same industry.
In the last couple of years the Operating Margin of KMDA has declined.
KMDA's Gross Margin of 43.47% is fine compared to the rest of the industry. KMDA outperforms 74.73% of its industry peers.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.46% | ||
| PM (TTM) | 8.99% | ||
| GM | 43.47% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
Compared to 1 year ago, KMDA has about the same amount of shares outstanding.
The number of shares outstanding for KMDA has been increased compared to 5 years ago.
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.11 indicates that KMDA is not in any danger for bankruptcy at the moment.
KMDA has a Altman-Z score of 3.11. This is in the better half of the industry: KMDA outperforms 77.05% of its industry peers.
The Debt to FCF ratio of KMDA is 0.30, which is an excellent value as it means it would take KMDA, only 0.30 years of fcf income to pay off all of its debts.
KMDA has a Debt to FCF ratio of 0.30. This is amongst the best in the industry. KMDA outperforms 96.44% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that KMDA is not too dependend on debt financing.
KMDA has a Debt to Equity ratio of 0.04. This is in the lower half of the industry: KMDA underperforms 60.68% of its industry peers.
Even though the debt/equity ratio score it not favorable for KMDA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.3 | ||
| Altman-Z | 3.11 |
ROIC/WACC0.55
WACC8.93%
2.3 Liquidity
A Current Ratio of 3.73 indicates that KMDA has no problem at all paying its short term obligations.
The Current ratio of KMDA (3.73) is comparable to the rest of the industry.
A Quick Ratio of 2.14 indicates that KMDA has no problem at all paying its short term obligations.
KMDA has a worse Quick ratio (2.14) than 72.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.09%, which is quite impressive.
The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
The Revenue has grown by 12.93% in the past year. This is quite good.
Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)26.09%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%75%
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%16.65%
3.2 Future
The Earnings Per Share is expected to grow by 19.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.74% on average over the next years. This is quite good.
EPS Next Y16.71%
EPS Next 2Y21.56%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year11.6%
Revenue Next 2Y10.42%
Revenue Next 3Y8.74%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 23.52 indicates a rather expensive valuation of KMDA.
94.84% of the companies in the same industry are more expensive than KMDA, based on the Price/Earnings ratio.
KMDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.85.
The Price/Forward Earnings ratio is 17.75, which indicates a rather expensive current valuation of KMDA.
91.99% of the companies in the same industry are more expensive than KMDA, based on the Price/Forward Earnings ratio.
KMDA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.89, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.52 | ||
| Fwd PE | 17.75 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaply inside the industry as 96.98% of the companies are valued more expensively.
97.51% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.64 | ||
| EV/EBITDA | 9.98 |
4.3 Compensation for Growth
KMDA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
KMDA has a very decent profitability rating, which may justify a higher PE ratio.
KMDA's earnings are expected to grow with 19.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y21.56%
EPS Next 3Y19.5%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.84%.
Compared to an average industry Dividend Yield of 93.64, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.40% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, KMDA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.84% |
5.2 History
KMDA does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y21.56%
EPS Next 3Y19.5%
NASDAQ:KMDA (5/15/2025, 10:42:51 AM)
6.82
-0.23 (-3.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.62%
Inst Owner Change-22.49%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap392.22M
Analysts84.44
Price Target15.05 (120.67%)
Short Float %0.1%
Short Ratio0.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.84% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.81%
Min EPS beat(2)2.94%
Max EPS beat(2)28.68%
EPS beat(4)3
Avg EPS beat(4)8.85%
Min EPS beat(4)-34.64%
Max EPS beat(4)38.4%
EPS beat(8)6
Avg EPS beat(8)5.89%
EPS beat(12)8
Avg EPS beat(12)-32.21%
EPS beat(16)8
Avg EPS beat(16)-102.42%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)0%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)4.89%
Revenue beat(8)2
Avg Revenue beat(8)-1.48%
Revenue beat(12)3
Avg Revenue beat(12)-1.91%
Revenue beat(16)4
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.5%
EPS NY rev (1m)2.59%
EPS NY rev (3m)-14.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.52 | ||
| Fwd PE | 17.75 | ||
| P/S | 2.44 | ||
| P/FCF | 10.64 | ||
| P/OCF | 8.24 | ||
| P/B | 1.51 | ||
| P/tB | 3.08 | ||
| EV/EBITDA | 9.98 |
EPS(TTM)0.29
EY4.25%
EPS(NY)0.38
Fwd EY5.63%
FCF(TTM)0.64
FCFY9.4%
OCF(TTM)0.83
OCFY12.13%
SpS2.8
BVpS4.51
TBVpS2.21
PEG (NY)1.41
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.88% | ||
| ROE | 5.57% | ||
| ROCE | 6.21% | ||
| ROIC | 4.91% | ||
| ROICexc | 6.48% | ||
| ROICexgc | 14.11% | ||
| OM | 12.46% | ||
| PM (TTM) | 8.99% | ||
| GM | 43.47% | ||
| FCFM | 22.9% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.3 | ||
| Debt/EBITDA | 0.28 | ||
| Cap/Depr | 77.78% | ||
| Cap/Sales | 6.67% | ||
| Interest Coverage | 33.76 | ||
| Cash Conversion | 140.57% | ||
| Profit Quality | 254.83% | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 3.11 |
F-Score7
WACC8.93%
ROIC/WACC0.55
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.09%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%75%
EPS Next Y16.71%
EPS Next 2Y21.56%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%16.65%
Revenue Next Year11.6%
Revenue Next 2Y10.42%
Revenue Next 3Y8.74%
Revenue Next 5YN/A
EBIT growth 1Y99.2%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year111.37%
EBIT Next 3Y35.35%
EBIT Next 5YN/A
FCF growth 1Y2500.91%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y1002.99%
OCF growth 3YN/A
OCF growth 5Y11.54%